OMB
.report
Search
AER records under FFDCA 760(e)(1) (21 U.S.C. 379aa(e)(1))
Postmarketing Adverse Drug Experience Reporting
0636 GFI on AER for NonRx Human Drug Products
AER records under FFDCA 760(e)(1) (21 U.S.C. 379aa(e)(1))
OMB: 0910-0230
OMB.report
HHS/FDA
OMB 0910-0230
ICR 202303-0910-017
IC 234420
AER records under FFDCA 760(e)(1) (21 U.S.C. 379aa(e)(1))
( )
⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0910-0230 can be found here:
2025-01-23 - Revision of a currently approved collection
Document [html]
Download:
html
File Type
inode/x-empty
File Modified
0000-00-00
File Created
0000-00-00
© 2025 OMB.report |
Privacy Policy